$8.03
-0.02-0.25%
al cierre: Nov 26, 4:00 PM EST
$7.90
-0.13-1.62%
After hour: 6:29 PM EST
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Relay Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
feb 25
Estimación de BPA
$-0.380
Estimación de ingresos trimestrales
$9.30M
Ingresos anuales
(a partir de sept 30)
(a partir de sept 30)
$8.36M
Analice el historial de beneficios de Relay Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RLAY | Relay Therapeutics | -$0.45 | -$0.38 | — | — | $0.00 | $9.30M | — | — | 02/25/2026 | |
RLAY | Relay Therapeutics | -$0.63 | -$0.41 | -$0.43 | -4.88% | $0.00 | $332.00K | $0.00 | -100.00% | 11/06/2025 | |
RLAY | Relay Therapeutics | -$0.69 | -$0.48 | -$0.41 | 14.58% | $0.00 | $245.00K | $677.00K | 176.33% | 08/07/2025 | |
RLAY | Relay Therapeutics | -$0.62 | -$0.51 | -$0.46 | 9.80% | $10.01M | $11.11K | $7.68M | 69017.91% | 05/05/2025 | |
RLAY | Relay Therapeutics | -$0.67 | -$0.55 | -$0.45 | 18.18% | $0.00 | $5.53M | $0.00 | -100.00% | 02/26/2025 | |
RLAY | Relay Therapeutics | -$0.54 | -$0.77 | -$0.63 | 18.18% | $25.20M | — | $0.00 | — | 11/06/2024 | |
RLAY | Relay Therapeutics | -$0.81 | -$0.73 | -$0.69 | 5.48% | $119.00K | $80.00K | $0.00 | -100.00% | 08/06/2024 | |
RLAY | Relay Therapeutics | -$0.78 | -$0.71 | -$0.62 | 12.68% | $226.00K | $90.00K | $10.01M | 11018.89% | 05/02/2024 | |
RLAY | Relay Therapeutics | -$0.56 | -$0.73 | -$0.67 | 8.22% | $253.00K | $130.00K | $0.00 | -100.00% | 02/22/2024 | |
RLAY | Relay Therapeutics | -$0.76 | -$0.83 | -$0.54 | 34.94% | $344.00K | — | $25.20M | — | 11/02/2023 | |
RLAY | Relay Therapeutics | -$0.71 | -$0.81 | -$0.81 | 0.00% | $365.00K | $750.00K | $119.00K | -84.13% | 08/08/2023 | |
RLAY | Relay Therapeutics | -$0.57 | -$0.69 | -$0.78 | -13.04% | $419.00K | $210.00K | $226.00K | 7.62% | 05/04/2023 | |
RLAY | Relay Therapeutics | -$0.62 | -$0.70 | -$0.56 | 20.00% | $567.00K | $3.30M | $253.00K | -92.33% | 02/23/2023 | |
RLAY | Relay Therapeutics | -$0.66 | -$0.71 | -$0.76 | -7.04% | $666.00K | $1.66M | $344.00K | -79.28% | 11/03/2022 | |
RLAY | Relay Therapeutics | -$0.64 | -$0.63 | -$0.71 | -12.70% | $844.00K | $1.93M | $365.00K | -81.09% | 08/04/2022 | |
RLAY | Relay Therapeutics | -$0.47 | -$0.62 | -$0.57 | 8.06% | $952.00K | $170.00K | $419.00K | 146.47% | 05/05/2022 | |
RLAY | Relay Therapeutics | $4.52 | — | -$0.62 | — | $82.65M | — | $567.00K | — | 02/24/2022 | |
RLAY | Relay Therapeutics | -$3.00 | -$0.64 | -$0.66 | -3.12% | $0.00 | $110.00K | $666.00K | 505.45% | 11/10/2021 | |
RLAY | Relay Therapeutics | — | -$0.45 | -$0.64 | -42.22% | — | $8.00M | $844.00K | -89.45% | 08/12/2021 | |
RLAY | Relay Therapeutics | -$5.99 | -$0.48 | -$0.47 | 2.08% | — | $952.00K | $952.00K | 0.00% | 05/13/2021 | |
RLAY | Relay Therapeutics | — | — | $4.52 | — | — | — | $82.65M | — | 03/25/2021 |
Relay Therapeutics (RLAY) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.43 | $-0.41 | -4.88 % |
| Q2 | 2025-08-07 | $-0.41 | $-0.48 | 14.6 % |
| Q1 | 2025-05-05 | $-0.46 | $-0.51 | 9.80 % |
| Q4 | 2025-02-26 | $-0.45 | $-0.55 | 18.2 % |
Relay Therapeutics (RLAY) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $0 | $332.00K | -100.0 % |
| Q2 | 2025-08-07 | $677.00K | $245.00K | 176.3 % |
| Q1 | 2025-05-05 | $7.68M | $11.11K | 69017.9 % |
| Q4 | 2025-02-26 | $0 | $5.53M | -100.0 % |
PREGUNTAS FRECUENTES
¿Cuándo Relay Therapeutics (NASDAQ:RLAY) publicará los resultados?
Está previsto que Relay Therapeutics (RLAY) presente resultados el febrero 25, 2026. Los últimos resultados se publicaron el noviembre 6, 2025 para el Q3.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Relay Therapeutics (NASDAQ:RLAY)?
El BPA real fue de $-0.43, que no alcanzó la estimación de $-0.41.
¿Cuáles fueron los ingresos de Relay Therapeutics (NASDAQ:RLAY)?
Los ingresos reales fueron $0K, que no alcanzó la estimación de $332K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.